yokukansankachimpihange

has antipruritic activity; consists of Atractylodes lanceae rhizome, Angelica dahurica root, Bupleurum root, Citrus unshiu peel, Cnidium rhizome, Glycyrrhiza, Poria sclerotium, Pinellia tuber, and Uncaria hook

Also Known As:

Networked: 14 relevant articles (4 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Norimoto, Hisayoshi: 3 articles (08/2015 - 08/2013)
2.	Michihara, Seiwa: 2 articles (01/2021 - 09/2014)
3.	Takahashi, Ryuji: 2 articles (01/2021 - 01/2020)
4.	Murayama, Chiaki: 2 articles (08/2015 - 09/2014)
5.	Aoki, Yayoi: 1 article (01/2021)
6.	Han, Li-Kun: 1 article (01/2021)
7.	Kaneda, Marisa: 1 article (01/2021)
8.	Shimoyama, Taiki: 1 article (01/2021)
9.	Fujita, Nina: 1 article (01/2020)
10.	Ishida, Toru: 1 article (01/2020)

Related Diseases

1.	Dementia (Dementias) 01/01/2020 - "There are no multicenter studies of its effectiveness regarding dementia in Japan, and this study's main objective was to clarify the effects of Yokukansankachimpihange on behavioral and psychological symptoms of dementia in a sample of patients from multiple healthcare centers. " 01/01/2020 - "Yokukansankachimpihange Is Useful to Treat Behavioral/Psychological Symptoms of Dementia." 01/01/2017 - "Yokukansankachimpihange (YKSCH), a traditional Japanese medicine, is widely used for the amelioration of the behavioral and psychological symptoms of dementia with digestive dysfunction. " 01/01/2020 - "Because the aggressiveness and sleep disorder components of the Behave-AD construct were the symptoms most improved and those symptoms are known to significantly burden dementia patients' caregivers, Yokukansankachimpihange's efficacy might indirectly relieve these caregivers' burden of care." 01/01/2020 - "Pharmaceutical treatments are important for treating behavioral and psychological symptoms of dementia, and this study confirmed Yokukansankachimpihange's efficacy for treating Alzheimer's disease. "
2.	Alzheimer Disease (Alzheimer's Disease) 01/01/2020 - "Nine facilities affiliated with Osaka Association of Psychiatric Clinics participated in November 2013 through April 2015 and provided 32 Alzheimer's disease patients to whom Yokukansankachimpihange was orally administered for 8 weeks. " 01/01/2020 - "Pharmaceutical treatments are important for treating behavioral and psychological symptoms of dementia, and this study confirmed Yokukansankachimpihange's efficacy for treating Alzheimer's disease. " 12/01/2018 - "Decreased Behavioral Abnormalities After Treatment with Combined Donepezil and Yokukansankachimpihange in Alzheimer Disease: An Observational Study. " 12/01/2018 - "We performed an observational study using yokukansankachimpihange, which contains a nobiletin-rich Citrus reticulata, to determine whether it could improve BPSD as well as cognitive impairment in patients with Alzheimer disease (NINCDS-ADRDA). "
3.	REM Sleep Behavior Disorder 01/01/2020 - "A Preliminary Trial in the Efficacy of Yokukansankachimpihange on REM Sleep Behavior Disorder in Dementia With Lewy Bodies."
4.	Parkinson Disease (Parkinson's Disease) 06/01/2018 - "Efficacy of Yokukansankachimpihange on sleep disturbance in Parkinson's disease: A study protocol of a randomized, double blind, placebo-controlled pilot trial."
5.	Sleep Wake Disorders 01/01/2020 - "Because the aggressiveness and sleep disorder components of the Behave-AD construct were the symptoms most improved and those symptoms are known to significantly burden dementia patients' caregivers, Yokukansankachimpihange's efficacy might indirectly relieve these caregivers' burden of care." 01/01/2020 - "Yokukansankachimpihange is a Japanese herbal medicine reported to benefit anxiety and sleep disorders, and it has recently been introduced to treat behavioral and psychological symptoms of dementia. "

Related Drugs and Biologics

1.	Yi-Gan San
2.	Plant Extracts
3.	Memantine (Namenda)
4.	Donepezil (Aricept)
5.	nobiletin

Related Therapies and Procedures

1.	Kampo Medicine (Kampo)
2.	Aftercare (After-Treatment)